Author:
Jia Yue-ran,Guo Zi-qing,Guo Qian,Wang Xiao-chuan
Publisher
Springer Science and Business Media LLC
Reference77 articles.
1. Gauthier S, Webster C, Servaes S, eds. World Alzheimer Report 2022: Life after diagnosis: Navigating treatment, care and support. London: Alzheimer’s Disease International, 2022.
2. Takashima A. GSK-3 is essential in the pathogenesis of Alzheimer’s disease. J Alzheimers Dis JAD, 2006,9(3 Suppl):309–317
3. Kimura T, Ishiguro K, Hisanaga SI. Physiological and pathological phosphorylation of tau by Cdk5. Front Mol Neurosci, 2014,7:65
4. Jia L, Du Y, Chu L, et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health, 2020,5(12):e661–e671
5. Tiraboschi P, Hansen LA, Masliah E, et al. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease. Neurology, 2004,62(11): 1977–1983